EN PL
PRACA ORYGINALNA
Ocena przydatności autofluorescencji skóry jak wskaźnika aktywności choroby i ryzyka wystąpienia cukrzycy u chorych na reumatoidalne zapalenie stawów
 
Więcej
Ukryj
 
Data nadesłania: 26-10-2015
 
 
Data ostatniej rewizji: 05-11-2015
 
 
Data akceptacji: 07-11-2015
 
 
Data publikacji online: 08-12-2015
 
 
Data publikacji: 31-10-2015
 
 
Reumatologia 2015;53(5):247-251
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Objectives: Diabetes develops much more often in patients suffering from rheumatoid arthritis (RA) than in healthy population. One of the parameters which allow to evaluate the risk of developing diabetes and cardiovascular diseases (CVD) is the level of advanced glycation end products (AGE) in the skin. In patients suffering from RA, an increase in AGE level may be also linked with the course of the underlying disease. The aim of the study was to evaluate the correlation between the AGE level and the course of RA as well as other risk factors for the development of diabetes and CVD.
Material and methods: The study included 148 patients divided into three groups: group I – patients with RA (n = 102, 79 F/23 M), group II – patients with RA and diabetes (n = 21, 14 F/7 M), group III – healthy individuals (n = 25, 16 F/9 M). Each patient underwent a skin autofluorescence signal (SAF) examination with an AGE Reader, which allows the assessment of AGE level, as well as being subjected to the laboratory tests panel. Additionally, patients from group I and II have had their DAS28 (ESR) indicator calculated.
Results: In groups I, II, and III, the respective mean SAF values, expressed in arbitrary units [au], were to 2.54, 2.74, and 1.96 au. Between-group differences in terms of mean SAF values were statistically significant (p < 0.05).
Conclusions: Significantly higher mean SAF values in groups I and II as compared to group III suggest that the increase in the AGE level in patients with RA is linked with the underlying disease and does not have to correspond with the real risk of diabetes and CVD. In conclusion, despite the known limitations of the technique, measuring AGE levels allows for closer monitoring of RA patients who are at a higher risk of developing diabetes.
 
REFERENCJE (15)
1.
Olas J, Gajos G, Bucka J. Cardiovascular mortality in rheumatoid arthritis patients. Post Dermatol Alergol 2006; 23: 26-30.
 
2.
Cojocaru M, Cojocaru IM, Silosi J, Vrabied CD. Metabolic syndrome in rheumatoid arthritis. Maedica (Buchar) 2012; 7: 148-152.
 
3.
Walewska E, Rupiński R, Filipowicz-Sosnowska A. Zaburzenia metabolizmu glukozy u chorych na reumatoidalne zapalenie stawów. Reumatologia 2008; 46: 356-360.
 
4.
Simard JF, Mittleman MA. Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. J Rheumatol 2007; 34: 469-473.
 
5.
Doran M. Rheumatoid arthritis and diabetes mellitus: evidence for an association? J Rheumatol 2007; 34: 460-462.
 
6.
van Deutekom AW, Nurmohamed MT, Peters MJ, et al. Methotrexate and its effect on the anti-GAD titre in two patients with rheumatoid arthritis and diabetes mellitus. Ann Reum Dis 2008; 67: 1051-1052.
 
7.
Sieradzki J, Grzeszczak W, Wójcikowski C i wsp. oraz grupa badaczy SCREEN-POL. Czynniki ryzyka i objawy cukrzycy a występowanie cukrzycy w badaniach SCREEN-POL. Diabetol Pol 1999; 6 supl. 2: S212-S223.
 
8.
Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischaemic heart disease. N Engl J Med 1996; 334: 952-957.
 
9.
Szczęsny W, Żuchowski P, Fisz JJ, et al. The ultrastructure of rectus sheath in patients with inguinal hernias and healthly controls – an evaluation by fluorescent spectroscopy and microspectrometric techniques. Hernia 2009; 13: 64-65.
 
10.
Chwirot B, Chwirot S, Sypniewska N, et al. Fluorescence in situ detection of human cutaneous melanoma: study of diagnostic parameters of the method. J Invest Dermatol 2001; 117: 1449-1451.
 
11.
Jeka S, Prochorec-Sobieszek M. Zastosowanie spektroskopii fluorescencyjnej w diagnostyce amyloidozy – doniesienie wstępne. Reumatologia 2010; 48: 230-236.
 
12.
Stirban A, Heinemann L. Skin autofluorescence – a non-invasive measurement for assessing cardiovascular risk and risk of diabetes. European Endocrinology 2014; 10: 106-110.
 
13.
de Groot L, Hinkema H, Westra, et al. Advanced glycation end products are increased in rheumatoid arthritis patients with controlled diseases. Arthritis Res Ther 2011; 13: R205.
 
14.
Kulbacka J, Saczko J, Chwiłkowska A. Oxidative stress in cells damage processes. Pol Merkur Lekarski 2009; 27: 44-47.
 
15.
Grassi W, Gaywood I, Pande I, et al. From DAS 28 to SAS 1. Clin Exp Rheumatol 2012; 30: 649-651.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top